Piperlongumine could promote apoptosis and suppress tumour growth in vitro and in vivo by inhibiting the DNA binding activity of nuclear factor-κB (NF-κB) in lung cancer due to a direct interaction between piperlongumine and the p50 subunit of NF-κB [81]. This evidence concerns the gene NFKB1 and neoplasm.